1.90
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ACRS Giù?
Forum
Previsione
Aclaris Therapeutics Inc Borsa (ACRS) Ultime notizie
Automated trading signals detected on Aclaris Therapeutics Inc.July 2025 Earnings & Low Risk Entry Point Guides - newser.com
Why Aclaris Therapeutics Inc. stock attracts global investorsAnalyst Downgrade & Stepwise Entry and Exit Trade Signals - newser.com
Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY) and Aclaris Therapeutics (ACRS) - The Globe and Mail
Will Aclaris Therapeutics Inc. stock outperform international peers2025 Risk Factors & Daily Stock Trend Watchlist - newser.com
What high frequency data says about Aclaris Therapeutics Inc.Market Sentiment Review & Safe Capital Allocation Plans - newser.com
Using data models to predict Aclaris Therapeutics Inc. stock movement2025 Biggest Moves & AI Forecast for Swing Trade Picks - newser.com
Cantor Fitzgerald maintains Overweight on Aclaris stock, cites multi-bagger potential - Investing.com UK
Applying Elliott Wave Theory to Aclaris Therapeutics Inc.July 2025 Recap & Entry Point Confirmation Signals - newser.com
Aclaris Therapeutics’ (ACRS) Sell (E+) Rating Reaffirmed at Weiss Ratings - Defense World
Full technical analysis of Aclaris Therapeutics Inc. stockAnalyst Upgrade & Consistent Profit Focused Trading Strategies - newser.com
Aclaris Therapeutics Announces New Employee Stock Grants Under 2024 Inducement Plan - MSN
Aclaris Therapeutics, Inc. Hosts R&D Day Highlighting Therapeutic Innovations - TradingView
How Aclaris Therapeutics Inc. stock trades before earningsJuly 2025 Fed Impact & High Yield Equity Trading Tips - newser.com
Will Aclaris Therapeutics Inc. stock outperform Dow Jones index2025 Top Gainers & AI Enhanced Trading Alerts - newser.com
Published on: 2025-10-14 03:19:57 - newser.com
Using Python tools to backtest Aclaris Therapeutics Inc. strategiesJuly 2025 Gainers & Growth Focused Entry Reports - newser.com
Is Aclaris Therapeutics (NASDAQ:ACRS) In A Good Position To Invest In Growth? - Yahoo Finance
Building trade automation scripts for Aclaris Therapeutics Inc.2025 Trade Ideas & Weekly Momentum Picks - newser.com
Real time alert setup for Aclaris Therapeutics Inc. performanceQuarterly Portfolio Review & Fast Exit and Entry Trade Guides - newser.com
Real time breakdown of Aclaris Therapeutics Inc. stock performanceJuly 2025 Technicals & Fast Exit and Entry Trade Guides - newser.com
Is Aclaris Therapeutics Inc. (8AT) stock testing key supportGDP Growth & Stock Portfolio Risk Control - newser.com
Atopic Dermatitis Pipeline Outlook Report 2025: Insight into emerging drugs, treatment options, clinical trials, and company strategies - The Globe and Mail
What analysts say about Aclaris Therapeutics Inc 8AT stockMarket Sentiment Shifts & Outperform the Market with Aggressive Picks - earlytimes.in
How Aclaris Therapeutics Inc. stock performs during Fed tightening cyclesEarnings Recap Report & Weekly Top Gainers Alerts - newser.com
Sentiment analysis tools applied to Aclaris Therapeutics Inc.July 2025 Catalysts & Risk Adjusted Buy/Sell Alerts - newser.com
Will Aclaris Therapeutics Inc. rebound enough to break evenRate Cut & High Accuracy Trade Signal Alerts - newser.com
Risk vs reward if holding onto Aclaris Therapeutics Inc.July 2025 Earnings & Reliable Volume Spike Alerts - newser.com
Real time scanner hits for Aclaris Therapeutics Inc. explainedCEO Change & Daily Stock Trend Reports - newser.com
Will Aclaris Therapeutics Inc. (8AT) stock profit from automation waveGold Moves & High Yield Equity Trading Tips - newser.com
Aclaris to Host 2025 R&D Day in New York to Spotlight Immuno-Inflammatory Pipeline - MyChesCo
Using Bollinger Bands to evaluate Aclaris Therapeutics Inc.July 2025 PostEarnings & High Yield Stock Recommendations - newser.com
How high can Aclaris Therapeutics Inc. stock goCPI Data & Free Community Supported Trade Ideas - newser.com
Will Aclaris Therapeutics Inc. (8AT) stock beat revenue estimatesWeekly Trade Review & Accurate Intraday Trade Tips - newser.com
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):